Regencell Bioscience Holdings Ltd (RGC) stock
RGCNasdaqMedicinal Chemicals & Botanical Products
$4.55−0.17 (-3.60%)
Close on Nov 17, 2026Market cap $2.26BP/E –Yield –
Regencell Bioscience enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Regencell Bioscience's enterprise value was $2.67B on Nov 11, 2026, against $5.70B a year earlier. Over the last 5 years it ranged from $32.11M to $14.45B, with a median of $344.03M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.67B | -74.3% |
| 2025 | Dec 31, 2025 | $10.38B | +18328.5% |
| 2024 | Dec 31, 2024 | $56.32M | -54.9% |
| 2023 | Dec 29, 2023 | $125.02M | -63.9% |
| 2022 | Dec 30, 2022 | $346.50M | +8.8% |
| 2021 | Dec 31, 2021 | $318.46M | – |
See a number that looks wrong?